HEALTH CHECK
16/05/24 -"As we have consistently argued over the last 3 years, Health stocks (ex Pharma) are long on growth promises and short on delivery. The gap stems from the fact that delivery hinges on buying the next ..."
Pages
49
Language
English
Published on
16/05/24
You may also be interested by these reports :
25/02/26
Ageas delivered FY25 broadly in line with expectations, with net operating profit up 33% y/y to €1.65bn, boosted by a €300m China tax one-off. ...
24/02/26
We have incorporated Aegon’s recently published 2H25 results into our model, and revised our assumptions accordingly. In 2H25, IFRS operating profit ...
24/02/26
Aegon’s 2H25 results came in above expectations at both IFRS operating profit and OCG levels. However, the outperformance was partly driven by ...
23/02/26
In FY25, Zurich reported double-digit increases in operating profit and net income, driven by all three businesses. Net income attributable to ...